Editorial: Neurological Comorbidity in Metabolic Syndrome
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Zhu G, Zhao J, Zhang H, Chen W, Wang G
. Probiotics for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis. Foods. 2021; 10(7).
PMC: 8303183.
DOI: 10.3390/foods10071672.
View
2.
Whitmer R, Sidney S, SELBY J, Johnston S, Yaffe K
. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64(2):277-81.
DOI: 10.1212/01.WNL.0000149519.47454.F2.
View
3.
Stanciu G, Bild V, Ababei D, Rusu R, Cobzaru A, Paduraru L
. Link Between Diabetes and Alzheimer's Disease due to the Shared Amyloid Aggregation and Deposition Involving both Neurodegenerative Changes and Neurovascular Damages. J Clin Med. 2020; 9(6).
PMC: 7357086.
DOI: 10.3390/jcm9061713.
View
4.
Etchegoyen M, Nobile M, Baez F, Posesorski B, Gonzalez J, Lago N
. Metabolic Syndrome and Neuroprotection. Front Neurosci. 2018; 12:196.
PMC: 5919958.
DOI: 10.3389/fnins.2018.00196.
View
5.
Yaffe K, Bahorik A, Hoang T, Forrester S, Jacobs Jr D, Lewis C
. Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study. Neurology. 2020; 95(7):e839-e846.
PMC: 7605504.
DOI: 10.1212/WNL.0000000000010078.
View